Subpart-E accelerated approval applies only to biologics; for small-molecule drugs such as Telaprevir, the corresponding FDA reg is Subpart H. The basic idea is the same, however.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”